SwRI Receives $9.9 Million to Develop Nerve Agent Antidote
March 25, 2020
March 25, 2020
SAN ANTONIO, Texas, March 25 -- Southwest Research Institute issued the following news release:
Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.
The use of nerve agents continues to be a significant threat to both military and civilian populations. This prototype medication . . .
Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.
The use of nerve agents continues to be a significant threat to both military and civilian populations. This prototype medication . . .